Publicaciones (79) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

  2. A Dual Role for FADD in Human Precursor T-Cell Neoplasms

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  3. A developmental delay linked missense mutation in Kalirin-7 disrupts protein function and neuronal morphology

    Frontiers in Molecular Neuroscience, Vol. 15

  4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis

    Brain : a journal of neurology, Vol. 145, Núm. 8, pp. 2671-2676

  5. An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer

    Molecular Therapy - Nucleic Acids, Vol. 30, pp. 553-568

  6. Associations between telomere length and symptoms of posttraumatic stress disorder and appetitive aggression in trauma-exposed men

    Neuroscience Letters, Vol. 769

  7. Astrogenesis in the murine dentate gyrus is a life-long and dynamic process

    EMBO Journal, Vol. 41, Núm. 11

  8. BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells

    Frontiers in Cell and Developmental Biology, Vol. 10

  9. BMP9 Promotes an Epithelial Phenotype and a Hepatocyte-like Gene Expression Profile in Adult Hepatic Progenitor Cells

    Cells, Vol. 11, Núm. 3

  10. Beyond autophagy: LC3-associated phagocytosis and endocytosis

    Science Advances, Vol. 8, Núm. 43

  11. Biosensing Tacrolimus in Human Whole Blood by Using a Drug Receptor Fused to the Emerald Green Fluorescent Protein

    Analytical Chemistry, Vol. 94, Núm. 47, pp. 16337-16344

  12. CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes

    International journal of molecular sciences, Vol. 23, Núm. 6

  13. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  14. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

  15. Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells

    Clinical and Experimental Allergy, Vol. 52, Núm. 4, pp. 540-549

  16. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

    Mucosal Immunology, Vol. 15, Núm. 1, pp. 96-108

  17. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1320-1332

  18. Childhood trauma, the stress response and metabolic syndrome: A focus on DNA methylation

    European Journal of Neuroscience, Vol. 55, Núm. 9-10, pp. 2253-2296

  19. Clinical trials in pediatric ALS: a TRICALS feasibility study

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 23, Núm. 7-8, pp. 481-488

  20. Cognitive functioning in essential tremor without dementia: a clinical and imaging study

    Neurological Sciences, Vol. 43, Núm. 8, pp. 4811-4820